• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国肝细胞癌患者的健康相关生活质量及其影响因素:一项横断面研究。

Health-related quality of life in Thai patients with hepatocellular carcinoma and its influencing factors: A cross-sectional study.

作者信息

Pathomjaruwat Thitiporn, Matchim Yaowarat, Armer Jane M

机构信息

Faculty of Nursing, Thammasat University, Pathum Thani, Thailand.

Sinclair School of Nursing, University of Missouri, Columbia, USA.

出版信息

Belitung Nurs J. 2025 Aug 3;11(4):370-383. doi: 10.33546/bnj.3853. eCollection 2025.

DOI:10.33546/bnj.3853
PMID:40766262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12319692/
Abstract

BACKGROUND

Health-related quality of life (HRQoL) is a critical indicator in individuals with cancer. Patients diagnosed with hepatocellular carcinoma (HCC) commonly experience a decline in HRQoL due to both the progression of the disease and the adverse effects associated with treatment. Despite the high prevalence of HCC in Thailand, there is a paucity of research examining the HRQoL of Thai patients and the factors that may influence it.

OBJECTIVE

This study aimed to examine HRQoL in Thai patients with HCC and evaluated the relationships between disease stage, comorbidities, albumin level, functional status (FS), self-management behaviors (SMBs), and HRQoL.

METHODS

A correlational, cross-sectional study was conducted with 408 patients with HCC recruited from six hospitals in central Thailand between April and September 2024. Data collection included demographic and clinical information, along with the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) scale, Inventory of Functional Status-Cancer (IFS-CA), and the SMB scale for patients with HCC. All instruments were validated and reliable. Data were analyzed using descriptive statistics and multiple regression analysis.

RESULTS

Most participants were at intermediate (38.97%) or advanced (24.26%) stages of HCC. Overall HRQoL was high (mean FACT-Hep score = 147.92 ± 26.09). Disease stage, comorbidities, albumin level, FS, and SMBs were all significantly correlated with HRQoL ( = 0.771). Together, these factors explained 58.9% of the variance in HRQoL ( = 0.589, = 117.745, <0.001). Significant predictors of HRQoL included disease stage (β = -0.116), comorbidities (β = -0.080), albumin level (β = 0.278), FS (β = 0.388), and SMBs (β = 0.296). Among these, FS was the strongest predictor.

CONCLUSION

Improving self-management behaviors, functional status, and nutritional status shows promise for enhancing HRQoL in patients with HCC. These findings can guide nurses in developing interventions to support patients with HCC and improve their quality of life.

摘要

背景

健康相关生活质量(HRQoL)是癌症患者的一项关键指标。被诊断为肝细胞癌(HCC)的患者通常会因疾病进展和治疗相关不良反应而出现HRQoL下降。尽管泰国HCC的患病率很高,但针对泰国患者的HRQoL及其可能影响因素的研究却很少。

目的

本研究旨在调查泰国HCC患者的HRQoL,并评估疾病分期、合并症、白蛋白水平、功能状态(FS)、自我管理行为(SMBs)与HRQoL之间的关系。

方法

2024年4月至9月,对从泰国中部六家医院招募的408例HCC患者进行了一项相关性横断面研究。数据收集包括人口统计学和临床信息,以及癌症治疗-肝胆功能评估(FACT-Hep)量表、癌症功能状态量表(IFS-CA)和HCC患者的SMB量表。所有工具均经过验证且可靠。数据采用描述性统计和多元回归分析。

结果

大多数参与者处于HCC的中期(38.97%)或晚期(24.26%)。总体HRQoL较高(FACT-Hep平均得分=147.92±26.09)。疾病分期、合并症、白蛋白水平、FS和SMBs均与HRQoL显著相关(=0.771)。这些因素共同解释了HRQoL方差的58.9%(=0.589,=117.745,<0.001)。HRQoL的显著预测因素包括疾病分期(β=-0.116)、合并症(β=-0.080)、白蛋白水平(β=0.278)、FS(β=0.388)和SMBs(β=0.296)。其中,FS是最强的预测因素。

结论

改善自我管理行为、功能状态和营养状况有望提高HCC患者的HRQoL。这些发现可为护士制定支持HCC患者并改善其生活质量的干预措施提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1230/12319692/0c87743d9796/BNJ-11-4-370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1230/12319692/3ca0edd589e4/BNJ-11-4-370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1230/12319692/d83250830de2/BNJ-11-4-370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1230/12319692/0c87743d9796/BNJ-11-4-370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1230/12319692/3ca0edd589e4/BNJ-11-4-370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1230/12319692/d83250830de2/BNJ-11-4-370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1230/12319692/0c87743d9796/BNJ-11-4-370-g003.jpg

相似文献

1
Health-related quality of life in Thai patients with hepatocellular carcinoma and its influencing factors: A cross-sectional study.泰国肝细胞癌患者的健康相关生活质量及其影响因素:一项横断面研究。
Belitung Nurs J. 2025 Aug 3;11(4):370-383. doi: 10.33546/bnj.3853. eCollection 2025.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Exercise interventions on health-related quality of life for people with cancer during active treatment.积极治疗期间针对癌症患者健康相关生活质量的运动干预措施。
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD008465. doi: 10.1002/14651858.CD008465.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
7
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
8
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
9
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
10
Rehabilitation for ankle fractures in adults.成人踝关节骨折康复。
Cochrane Database Syst Rev. 2024 Sep 23;9(9):CD005595. doi: 10.1002/14651858.CD005595.pub4.

本文引用的文献

1
Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management.慢性肝病进展为肝细胞癌:对监测和管理的意义
BJC Rep. 2024 May 3;2(1):39. doi: 10.1038/s44276-024-00050-0.
2
Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis.肝细胞癌分期及肝功能与健康相关生活质量的关系:单中心分析
Healthcare (Basel). 2023 Sep 18;11(18):2571. doi: 10.3390/healthcare11182571.
3
Comorbidity burden and health-related quality of life in men with advanced prostate cancer.
晚期前列腺癌男性的合并症负担和与健康相关的生活质量。
Support Care Cancer. 2023 Jul 28;31(8):496. doi: 10.1007/s00520-023-07962-6.
4
Recent advances in recurrent hepatocellular carcinoma therapy.复发性肝细胞癌治疗的最新进展
World J Hepatol. 2023 Apr 27;15(4):460-476. doi: 10.4254/wjh.v15.i4.460.
5
Prognostic Scores and Survival Rates by Etiology of Hepatocellular Carcinoma: A Review.肝细胞癌病因的预后评分与生存率:综述
J Clin Med Res. 2023 Apr;15(4):200-207. doi: 10.14740/jocmr4902. Epub 2023 Apr 28.
6
Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis.随机临床试验中患有慢性疾病人群的合并症及与健康相关的生活质量:一项个体参与者数据荟萃分析。
PLoS Med. 2023 Jan 17;20(1):e1004154. doi: 10.1371/journal.pmed.1004154. eCollection 2023 Jan.
7
Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress.肝细胞癌当前治疗方法的专家见解:临床与分子方法及进展瓶颈
J Hepatocell Carcinoma. 2022 Dec 7;9:1247-1261. doi: 10.2147/JHC.S383922. eCollection 2022.
8
The impact of symptom distress on health-related quality of life in liver cancer patients receiving arterial chemoembolization: the mediating role of hope.症状困扰对接受肝动脉化疗栓塞治疗的肝癌患者健康相关生活质量的影响:希望的中介作用。
BMC Gastroenterol. 2022 Nov 15;22(1):456. doi: 10.1186/s12876-022-02529-x.
9
Changes in the Epidemiology of Hepatocellular Carcinoma in Asia.亚洲肝细胞癌流行病学的变化
Cancers (Basel). 2022 Sep 15;14(18):4473. doi: 10.3390/cancers14184473.
10
Functional Decline in the Cancer Patient: A Review.癌症患者的功能衰退:综述
Cancers (Basel). 2022 Mar 8;14(6):1368. doi: 10.3390/cancers14061368.